OTHER · Unmapped registry intervention
EMR-based BPA model
Find medicine records ·
Find other trials using this name
Clinical trial
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
NCT06931275
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
BEHAVIORAL · Unmapped registry intervention
Placebo (EMR-based without BPA model)
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedBest Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
Design: INTERVENTIONAL · Status: RECRUITING · Phase: NA
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetes Mellitus, Type 1unresolved
Interventions
EMR-based BPA modelOTHER
Placebo (EMR-based without BPA model)BEHAVIORAL
Sponsors & collaborators
T1D Exchange, United Stateslead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06931275 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.